New pharmaceutical formulations must be proven as safe and effective before entering
clinical trials. Also in the context of pulmonary drug delivery, preclinical models allow testing …

A series of sixteen ring-substituted N-arylcinnamamides was prepared and characterized.
Primary in vitro screening of all the synthesized compounds was performed against …

In this study, a series of twenty-two ring-substituted 6-hydroxynaphthalene-2-carboxanilides
was prepared and characterized. Primary in vitro screening of the synthesized compounds …

A series of fifteen new N-alkoxyphenylanilides of 3-hydroxynaphthalene-2-carboxylic acid
was prepared and characterized. Primary in vitro screening of the synthesized compounds …

In this study, a series of twenty-two ring-substituted 8-hydroxyquinoline-2-carboxanilides
was prepared and characterized. Primary in vitro screening of the synthesized compounds …

Current antitubercular drug therapy requires more than six months and is unable to kill latent
or dormant forms of tuberculosis. Thus, it is a need of new drug therapy to fight against …

A series of nineteen N-(alkoxyphenyl)-2-hydroxynaphthalene-1-carboxamides and a series
of their nineteen positional isomers N-(alkoxyphenyl)-1-hydroxynaphthalene-2 …

A series of twenty-two novel N-(disubstituted-phenyl)-3-hydroxynaphthalene-2-carboxamide
derivatives was synthesized and characterized as potential antimicrobial agents. N-[3, 5-bis …

In this study, a series of twenty-two ring-substituted naphthalene-1-carboxanilides were
prepared and characterized. Primary in vitro screening of the synthesized carboxanilides …

A series of twenty-six methoxylated and methylated N-aryl-1-hydroxynaphthalene-2-
carboxanilides was prepared and characterized as potential anti-invasive agents. The …